PGNX, PRTO, and ARTX SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
October 17, 2019 13:58 ET
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Progenics Pharmaceuticals, Inc. (NASDAQ GS: PGNX) regarding possible breaches of...
Progenics Pharmaceuticals Sets Second Quarter Financial Results Call for August 8
July 31, 2014 16:00 ET
|
Progenics Pharmaceuticals Inc.
TARRYTOWN, N.Y., July 31, 2014 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc., (Nasdaq:PGNX), an oncology company focused on developing innovative ways to target and treat prostate cancer,...